biotech · Presbyopia · Eye Diseases · LENZ
LENZ Therapeutics
LENZ Therapeutics clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- San Diego, USA
- Employees
- 176
- Programs
- 5
- Drugs
- 6
- Patents
- 20
LENZ Therapeutics projects
5 ClinicalTrials.gov programs sponsored by LENZ Therapeutics.
LENZ Therapeutics has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Aceclidine+Brimonidine combination ophthalmic solution
LENZ Therapeutics
Presbyopia
6 trials -
Aceclidine+tropicamide combination
LENZ Therapeutics
Presbyopia
1 trial -
PRX-100
LENZ Therapeutics
Presbyopia
1 trial -
Aceclidine + Brimonidine
LENZ Therapeutics
Eye Diseases
1 trial -
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution
LENZ Therapeutics
Presbyopia
1 trial
Frequently asked questions
How many clinical projects does LENZ Therapeutics have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.